We are pleased to inform you that we have received the approval of our Linagliptin 5mg tablets DCP (Decentralised Procedure) in The Netherlands, Italy, Spain, Poland, and Greece.
Please contact us at Info@intasb2b.com for more information.
To view region specific portfolio, click the relevant link below;
www.intasportfolio.com
